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Abstract Plant NADP-dependent malate dehydrogenase is 
activated through thiolldisulfide interchange with reduced 
thioredoxin. Previous studies showed that this process involves 
the reduction of two different disulfides per subunit: one N- 
terminal, the other C-terminal. Substitution of regulatory 
c> steines at each end by site-directed mutagenesis and compar- 
ison of activation kinetics of the mutants led us to propose a 
model for the activation mechanism where the C-terminal end 
shielded the access to the catalytic residues, whereas the N- 
terminal end was involved in the slow conformational change of 
the active site. In the present study, we took advantage of the 
previous identification of the catalytic histidine residue which can 
I~ specifically derivatized by diethyl pyrocarbonate to test the 
accessibility of the active site. The results clearly show that in the 
mutants where the C-terminal bridge is open the active site 
histidine is freely accessible to the reagent, whereas in the 
mutants where the N-terminal bridge is open, the active site 
cannot be reached without activation, thus demonstrating the 
validity of the model. 
I~,,y words." NADP-malate dehydrogenase; Light activation; 
S~te-directed mutagenesis; Thiol; Thioredoxin 
1, Introduction 
The major functional peculiarity of the chloroplastic 
N ADP-dependent malate dehydrogenase (NADP-MDH: EC 
1 1.1.82) resides in its activation properties. Unlike its NAD- 
dependent ubiquitous counterparts, it is totally inactive when 
o~idized, and fully active when reduced. This redox dependent 
p~ocess is mediated by thiol-disulfide interchange with the 
w:ry reactive disulfide bridge of thioredoxin. It constitutes 
the physiological means of regulation of the enzyme activity 
in vivo by switching it on (in the light) or off (in the dark) in 
accordance with the availability of the reducing power [1]. In 
a recent work [2~], we showed that two different disulfides 
h, ve to be reduced per subunit of this homodimeric enzyme 
dtLring the activation process. Both are located in sequence 
e~tensions specific for the redox-regulated forms: one at the 
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A~,breviations." CDM, double mutant NADP-malate dehydrogenase, 
matated on both C-terminal cysteines; NDM, double mutant NADP- 
malate dehydrogenase mutated on both N-terminal cysteines; DEPC, 
dit~thylpyrocarbonate; DTT, dithiothreitol; NADP-MDH, NADP- 
malate dehydrogenase; QM, quadruple mutant NADP-MDH, mu- 
tated on the four regulatory cysteines 
N-terminus, the other at the C-terminus [5]. By using site- 
directed mutagenesis techniques to substitute the cysteines at 
each end, we could obtain mutated enzymes bearing only one 
of the disulfides and study their activation kinetics. In the 
absence of the N-terminal disulfide, the reduction of the C- 
terminal bridge led to instantaneous activation of the enzyme. 
In contrast, when the C-terminal bridge was suppressed, the 
activation kinetics was slow: full activation took about 10-15 
min, as for the unmodified protein. This observation 
prompted us to propose different roles for the N- and C- 
terminal disulfides in activation. The reduction of the C-term- 
inal disulfide was proposed to uncover access to the active 
site, whereas the reduction of the N-terminal disulfide would 
trigger a conformational change shaping the active site in a 
fully active conformation. Further studies [6,7] identified His- 
229 and Asp-201 as the catalytically active residues, forming a 
proton relay system, as in the NAD-dependent dehydro- 
genases [8]. These residues are strictly conserved among all 
the malate dehydrogenases [9]. His-229 was shown to be spe- 
cifically derivatized with diethylpyrocarbonate (DEPC), lead- 
ing to the complete loss of catalytic activity [6]. The derivati- 
zation required preactivation f the enzyme, suggesting that in 
the inactivated protein, the catalytic site was screened from 
the solvent. Thus, DEPC treatment before or after activation 
seemed to be a good probe to check the accessibility of the 
active site. In the present study, we took advantage of this 
observation toexplore further the different roles of the N- and 
C-terminal disulfides in the activation process of sorghum leaf 
recombinant NADP-MDH. 
2. Materials and methods 
2.1. Production of WT and mutant proteins 
The WT and mutant recombinant proteins were obtained as de- 
scribed [2,4]. The site-directed mutagenesis technique of Kunkel [10] 
was used to introduce mutations in the WT [5] cDNA. The different 
cDNAs were cloned in the pET vector [11] and expressed in E. coli 
BL21 (DE3) strain. 
Among all the mutants created previously, three were retained for 
the present study: the N-terminal double cysteine mutant (NDM, 
corresponding to the mutation C24S/C29S), the C-terminal double 
cysteine mutant (CDM, corresponding to the mutation C365A/ 
C377A) and the quadruple cysteine mutant (QM) combining the mu- 
tations at both ends. It must be noted that the cysteine numbering 
differs from that used previously [2-4] by 40 residues. This difference 
corresponds to the residues for which it has been firmly established 
now that they belong to the transit peptide which is cleaved in the 
mature protein. 
2.2. Purification of the recombinant proteins 
The expressed proteins were purified to homogeneity b previously 
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described procedures [24] combining ammonium sulfate fractiona- 
tion, ion-exchange chromatography on DEAE-Sephacel, affinity chro- 
matography on Matrex redA and hydrophobic nteraction on phenyl- 
Sepharose HPLC. The N-terminus of each mutant protein was ver- 
ified by amino-terminal sequencing: in all cases, the transit peptide 
was removed by the bacteria, but the regulatory amino-terminal ex- 
tension was retained. 
Recombinant E. coli thioredoxin was purified as described pre- 
viously [12]. 
2.3. Standard assay for NADP-MDH activity 
The enzymes were preactivated by incubation in the presence of 10 
mM DTT and 20 gM thioredoxin from E. coli in pH 8, 100 mM Tris- 
HCI buffer. The activity was measured on aliquots (corresponding to
approx. 0.4 gg MDH) added to a spectrophotometer cuvette contain- 
ing 1 ml of reaction medium (140 gM NADPH, 760 gM oxaloacetate 
in 100 mM Tris-HC1 buffer, pH 8). In the case of the permanently 
active quadruple cysteine mutant, the reaction was started by adding 
the enzyme directly to the cuvette, without preincubation. The same 
procedure was followed when the spontaneous activity of the CDM 
was measured, but in this case, the oxaloacetate concentration was 
raised to 5 mM. The activity was estimated by the decrease in absor- 
bance at 340 nm. 
2.4. DEPC treatment 
The sensitivity of the WT and mutant NADP-MDH to DEPC was 
tested on either unactivated or previously activated enzymes. In the 
first case, the enzymes were preincubated with DEPC (freshly diluted 
in ethanol) for 5 min in 20 mM sodium phosphate buffer, pH 7.2. 
Then, the activation medium (10 mM DTT, 20 gM thioredoxin i  100 
mM Tris-HCl buffer, pH 8) was added, causing 5-fold dilution of the 
reagent. The activation of the enzyme was then measured as a func- 
tion of time, on aliquots. The control sample was treated with an 
equivalent volume of ethanol (10% final concentration). In the second 
case, the enzymes were preactivated by incubation with DTT and 
thioredoxin in 20 mM sodium phosphate buffer, pH 7.2. When full 
activation was reached, DEPC (or ethanol for the control) was added 
and MDH activity measured as a function of time, on aliquots. 
2.5. Preparation of DEPC-derivatized NADP-MDH: substrate 
protection 
To investigate he stability of the derivatization as well as the pro- 
tective effect of NADPH, the unactivated CDM enzyme (300 gg in 
500 I.tl of 20 mM phosphate buffer, pH 7.2) was pretreated with 1 mM 
DEPC, in the presence or absence of 1 mM NADPH. The unreacted 
reagent and cofactor were eliminated by centrifugation and extensive 
washing with 20 mM phosphate buffer pH 7.2 on Amicon Centricon 
30 concentrators (30 kDa cut-off). The dialyzed enzyme was subjected 
to activation with reduced thioredoxin, at pH 8, and its activity was 
measured on 0.4 I.tg aliquots. 
3. Results and discussion 
The previously created WT or mutant NADP-MDHs [24] 
were used for this investigation. The cDNAs were overex- 
pressed in E. coli using the very efficient pET expression sys- 
tem [11]. Since BL21(DE3) is not a RecA-  strain, the host 
bacteria were freshly transformed every time a new protein 
preparation was needed. The most productive clones (based 
on activity measurements in crude extracts) were retained for 
large scale (8 1) cultures and protein purification to homogen- 
eity by previously described procedures [2,4]. The mutated 
proteins were either double-cysteine mutations of the N-term- 
inal bridge (NDM) or the C-terminal bridge (CDM), or a 
quadruple mutation (QM) where both disulfides were substi- 
tuted (see methods for cysteine numbering). As shown pre- 
viously [4], the last mutant is a permanently active, thioredox- 
in-independent enzyme. 
The inhibitory effect of DEPC was first examined on fully 
activated proteins. DEPC being unstable under alkaline con- 
ditions, the preactivation was performed in phosphate buffer, 
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Fig. 1. Inhibition of fully activated (or permanently active) NADP- 
MDHs by DEPC. All the enzymes (except the permanently active 
QM) were first activated in the presence of 10 mM DTT and 20 
laM thioredoxin in 20 mM phosphate buffer pH 7.2. Then 1 mM 
DEPC was added and the activity measured on aliquots. The activ- 
ity is expressed as % of the activity of the fully activated enzymes: 
(D) WT enzyme; (O) QM; (11) NDM; (O) CDM; (A) NDM, 
DEPC 2 mM. The control samples (not shown for clarity) supple- 
mented with an equivalent amount of ethanol did not show more 
than a 5% decrease in activity within 10 min. 
pH 7.2, instead of pH 8 Tris-HC1 buffer. When full activation 
was reached, DEPC was added, and the activity of the en- 
zymes was measured on aliquots. Fig. 1 shows that all the 
enzymes were inhibited by DEPC, although with somewhat 
varying sensitivities. The N-terminal double mutant (NDM) 
behaved much the same way as the WT protein (50% inhibi- 
tion for 1 mM DEPC;  75% inhibition for 2 mM DEPC;  full 
inhibition (not shown) required 4 mM concentration). The C- 
terminal double mutant (CDM) was slightly more sensitive 
(75% inhibition for 1 mM DEPC). The most efficient inhibi- 
tion (over 95% with 1 mM DEPC) was achieved for the per- 
manently active quadruple cysteine mutant. However, it 
should be borne in mind that it is permanently active and 
did not require the addition of DTT and thioredoxin. Conse- 
quently, the access of the reagent to the active site of this 
mutant could be facilitated. Thus, besides somewhat different 
sensitivities to the reagent, all the activated, or permanently 
active, enzymes were inhibited by DEPC, like their NAD-de- 
pendent counterparts [13,14]. The results were quite different 
when DEPC was applied before activation (Fig. 2). The WT 
and NDM enzymes which have no activity without activation 
remained inactive after a 5 min DEPC treatment, but could be 
fully activated by the further addition of DTT and thioredox- 
in in pH 8 Tris buffer. This addition diluted the DEPC from 
1 mM to 0.2 mM. Moreover, the reagent is unstable at pH 8. 
This explains why no inhibition was observed after activation, 
and demonstrates that the active site of the unactivated NDM 
could not be reached by the reagent. In contrast, the faint 
spontaneous activity of the unactivated CDM protein which 
is observed at high oxaloacetate concentration [4] was almost 
fully inhibited by DEPC. The inhibition was not relieved by 
the further addition of the activation medium: the pretreated 
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enzyme could no longer be activated. Obviously, in this case, 
the catalytic histidine residue has been stably derivatized be- 
fore activation. Thus, in the unactivated CDM, the active site 
seems to be freely accessible to the reagent. 
Previous analytical work [6] based on tryptic digestion of 
the DEPC-derivatized protein and mass spectrometry analyses 
o! the tryptic peptides showed unambiguously that in the 
at ~ivated WT protein only the active-site His was derivatized 
b.~ DEPC. A good indication that the primary target of the 
retgent is indeed an active-site residue is provided by sub- 
st ate protection experiments. In the case of WT NADP- 
M DH, a good protection against inhibition was obtained by 
pl ~incubation with NADPH [6]. All the mutant enzymes 
te.,ted in the present work could be protected against DEPC 
inhibition by 1 mM NADPH, as well as the WT protein (data 
n t t  shown). In the case of the CDM and the QM whose 
atfivation (or permanent activity) is not inhibited by 
N kDP, the oxidized cofactor was also efficient in protection 
(d ~ta not shown). We took advantage of the substrate protec- 
tit n effect to confirm the accessibility of the active site to 
D2PC in the unactivated CDM and to assess the stability 
ol the derivatization (Fig. 3). The CDM enzyme was preincu- 
b;ited with DEPC, with or without NADPH. After 5 min, the 
sa nples were diluted with phosphate buffer and extensively 
di.tlyzed against he same buffer to eliminate the DEPC and 
N kDPH. The dialyzed proteins were then supplemented with 
th: activation medium and their activity measured as a func- 
ti, n of time. The sample previously incubated with NADPH 
c(uld be fully activated. The control sample remained inac- 
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Fi:;. 2. Effect of previous treatment with DEPC on further activa- 
tion of WT and mutant NADP-MDHs. The proteins were preincu- 
ba' ed for 5 rain with 1 mM DEPC in 20 mM phosphate buffer pH 
7.?. Then the activation medium (10 mM DTT+20 [aM thioredoxin 
in 100 mM Tris-HCl buffer pH 8) was added, diluting the DEPC 5- 
fod. The activity is expressed as % of the activity of the fully acti- 
vated proteins. Before the addition of DEPC, the spontaneous activ- 
it 3 of the different proteins was measured. Only the CDM exhibited 
a ~aint spontaneous activity before activation: it reached 8% of the 
act ivity of the fully activated protein when oxaloaeetate concentra- 
tiea was raised to 5 raM. All the other activity measurements were 
performed at standard (760 [aM) oxaloacetate concentration, as the 
activated enzymes are inhibited by excess oxaloacetate. 
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Fig. 3. Activation kinetics of the DEPC-pretreated, then dialyzed 
CDM malate dehydrogenase. Protective effect of NADPH. The 
CDM was preincubated with 1 mM DEPC for 5 min in the pres- 
ence or in the absence of 1 mM NADPH. In the presence of 
NADPH, its spontaneous activity, observed at high oxaloacetate 
concentration (see Fig. 2), was retained, whereas it disappeared in
the absence of the cofactor. The pretreated proteins were dialyzed 
extensively. Then the activation medium was added and the activity 
measured in standard conditions (i.e., low oxaloacetate: this ex- 
plains why the zero time activity in the presence of NADPH is very 
low). The activity is expressed as the decrease in absorbance at 
340 nm. 
rive, showing that the DEPC treatment led to a covalent 
modification of the catalytic histidine residue. 
In conclusion, the present results constitute the first direct 
evidence for the different spatial roles of the N- and C-term- 
inal disulfides in the activation of NADP-MDH.  They clearly 
demonstrate that the opening of the N-terminal disulfide 
bridge does not give access to the active site. In contrast, 
when the C-terminal disulfide is open, the active site histidine 
is fully accessible in the absence of substrates and can be 
specifically and stably derivatized even when the enzyme has 
not been activated. 
These results validate the previously proposed activation 
model [4] where the reduction of the C-terminal bridge opens 
the access to the active site whereas the reduction of the N- 
terminal bridge yields a slow conformational change giving 
the active site a fully active conformation. The precise nature 
of this conformational change is still to be defined. The cys- 
teines of the thioredoxin-dependent regulatory disulfides are 
not involved in catalysis [4] and an internal cysteine located at 
the active site can be substituted without major consequences 
for activity [15]. The other well-documented thioredoxin-de- 
pendent activation mechanism of a chloroplastic enzyme con- 
cerns phosphoribulokinase. In this case, only one disulfide 
bridge is reduced upon activation and both regulatory cys- 
teines are located at the active site [16]. For the other thiol- 
regulated chloroplastic enzymes, the sequence of events lead- 
ing to activation has not been clearly identified yet. Thus, in 
the present state of the art, the very sophisticated activation 
mechanism of NADP-malate dehydrogenase is rather unique 
among the thioredoxin activated chloroplastic enzymes. 
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